-
AstraZeneca to Acquire EsoBiotec for Cell Therapy Advancement
Mar 21 2025 -
Dyne’s DYNE-251: 18-Month Data Shows Unprecedented DMD Improvement
Mar 21 2025 -
Gene Therapy Investment Declines Amidst Successes and Economic Headwinds
Mar 21 2025 -
Novartis’ Intrathecal Zolgensma Shows Efficacy in Older SMA Patients
Mar 20 2025 -
Wugen Starts Pivotal Trial of Off-the-Shelf Allogeneic CD7 CAR-T (WU-CART-007)
Mar 20 2025 -
Sofinnova’s Biovelocita II Fund Closes at $181M, Backing Three New Biotech Companies
Mar 20 2025 -
RegCell Raises $45.8M for US Expansion of Treg Therapies
Mar 20 2025 -
Prime Medicine Announces AATD Gene Editing Program
Mar 20 2025 -
Beacon Therapeutics published 24-month safety and efficacy data from the AGTC-501 HORIZON Trial in the American Journal of Ophthalmology
Mar 19 2025